Rentschler tie-up with XL-protein expands CDMO's growing biotechnological toolbox
Rentschler Biopharma and XL-protein have teamed up on the manufacture of what they say is a long-acting, hyperactive recombinant human deoxyribonuclease I (DNase I) that may open better treatment options for patients suffering from inflammation, chronic or autoimmune diseases.
Source: biopharma-reporter.com